Multiomics for precision medicine
3 Apr 2025
Explore the vital role of multiomics in advancing 5P medicine—Predictive, Preventive, Participatory, Personalized, and Precision—particularly in tackling chronic diseases. In this video, Dr. Alice Limonciel, Chief Scientific Officer at Biocrates, discusses the field’s key challenges, the integration of metabolomics with other omics technologies, and real-world case studies that showcase its transformative impact on healthcare.
About the company
biocrates life sciences ag
About biocrates life sciences ag
Founded in 2002 and headquartered in Innsbruck, Austria, biocrates life sciences ag is a leading provider of targeted metabolomics solutions. The company’s products are trusted by top research institutions, pharmaceutical companies, and clinical laboratories around the world. biocrates is dedicated to advancing metabolomics through its high-quality, standardized kits, which enable the comprehensive analysis of metabolites in various biological systems.
